中访网数据山东新华制药股份有限公司(证券代码:000756)于近日宣布,其申报的缬沙坦胶囊(规格:80mg)已获得国家药品监督管理局核发的《药品注册证书》(证书编号:2025S03925)。该药品注册分类为化学药品4类,获批用于治疗轻、中度原发性高血压。缬沙坦胶囊属于《国家基本医疗保险、工伤保险和生育保险药品目录(2025年)》甲类品种。根据市场统计数据,2024年中国公立医疗机构该药品销售额约为...
Source Link中访网数据山东新华制药股份有限公司(证券代码:000756)于近日宣布,其申报的缬沙坦胶囊(规格:80mg)已获得国家药品监督管理局核发的《药品注册证书》(证书编号:2025S03925)。该药品注册分类为化学药品4类,获批用于治疗轻、中度原发性高血压。缬沙坦胶囊属于《国家基本医疗保险、工伤保险和生育保险药品目录(2025年)》甲类品种。根据市场统计数据,2024年中国公立医疗机构该药品销售额约为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.